A multicomponent reaction-initiated synthesis of imidazopyridine-fused isoquinolinones

  1. ,
  2. and
  3. ORCID Logo
Department of Chemistry, University of Massachusetts Boston, 100 Morrissey Boulevard, Boston, MA 02125, USA
  1. Corresponding author email
Associate Editor: L. Vaccaro
Beilstein J. Org. Chem. 2025, 21, 1161–1169. https://doi.org/10.3762/bjoc.21.92
Received 20 Mar 2025, Accepted 05 Jun 2025, Published 13 Jun 2025
A non-peer-reviewed version of this article has been posted as a preprint https://doi.org/10.3762/bxiv.2025.20.v1
Full Research Paper
cc by logo

Abstract

A new synthetic route initiated with Groebke–Blackburn–Bienaymé (GBB) followed by N-acylation, intramolecular Diels–Alder (IMDA), and dehydrative re-aromatization reactions for the synthesis of imidazopyridine-fused isoquinolinones is developed. Gaussian computation analysis on the effect of the substitution groups for the IMDA reaction is performed to understand the reaction mechanism.

Introduction

Multicomponent reactions (MCRs) have intrinsic green chemistry advantages of synthetic efficiency and operational simplicity. Performing post-condensational modifications of MCRs could generate novel and complex molecular scaffolds . Some MCR adducts generated from Ugi, Passerini, Gewald, Biginelli, and Groebke–Blackburn–Bienaymé (GBB) reactions have been modified to form chemically diverse heterocyclic scaffolds with potential biological activities .

Imidazo[1,2-a]pyridine and isoquinolinone-kind scaffolds are privileged rings which can be found in drug molecules such as zolimidine , zolpidem , alpidem and antiemetic drug 5-HT3A antagonist palonosetron (Figure 1). Imidazopyridine-fused isoquinolinones have been developed as HIV inhibitors . The imidazo[1,2-a]pyridine ring can be readily synthesized by the GBB reaction , while the isoquinolinone ring is commonly generated by a cyclative lactamization process. Performing a GBB reaction followed by an intramolecular amidation is a good approach for making imidazopyridine-fused isoquinolinones.

[1860-5397-21-92-1]

Figure 1: Bioactive compounds bearing imidazopyridine (red) and isoquinolinone-kind (blue) rings.

The Veljkovic group employed methyl 2-formylbenzoate for the GBB reaction to form adducts I which undergoes intramolecular amidation to afford product A (Scheme 1A) . In a patent filed by Tibotec Pharmaceuticals, substituted alkyl isonitriles were used for the GBB reaction followed by the cleavage of the alkyl group to give intermediate II as a free amine. Annulation of II with CDI gave product B which is an HIV reverse transcriptase inhibitor (Scheme 1B) . We have reported a three-component [3 + 2] cycloaddition followed by IMDA reaction for making heterocyclic compounds . Presented in this paper is a new synthetic route involving GBB, N-acylation and IMDA reactions for making intermediate III followed by dehydrative re-aromatization to give imidazopyridine-fused isoquinolinones C (Scheme 1C).

[1860-5397-21-92-i1]

Scheme 1: GBB-initiated synthesis of imidazopyridine-fused isoquinolinones.

Results and Discussion

Following the reported procedures , the initial GBB reaction of aminopyridines 1 (0.5 mmol), isocyanides 3 (1.2 equiv), and furfuraldehydes 2 (1.2 equiv) was conducted in 3:1 CH2Cl2/MeOH (4 mL) using Yb(OTf)3 (0.08 equiv) as a Lewis acid catalyst under microwave irradiation at 100 °C for 1 h (Scheme 2). Nineteen distinct adducts 4 were obtained in 89–98% yields. Reactions of 4 with acryloyl chloride (5, 1.5 equiv) in the presence of Et3N (2 equiv) at room temperature in anhydrous CH2Cl2 for 6 h afforded 19 N-acylated compounds 6 in 80–90% yields .

[1860-5397-21-92-i2]

Scheme 2: GBB reaction and N-acylation for the preparation of imidazo[1,2-a]pyridines 6.

With N-acylated GBB adducts 6 in hand, the synthesis of imidazopyridine-fused isoquinolinones 8 was explored by conducting IMDA and spontaneous dehydrative re-aromatization reactions. The IMDA reaction using 6a as a model compound was systematically evaluated by varying catalysts, solvents, reaction temperatures and times (Table 1). The best conditions were found to use AlCl3 as a catalyst in 1,2-dichlorobenzene at 180 °C for 4 h, which gave 8a in 85% conversion and 82% isolated yield (Table 1, entry 3). Other solvents like toluene and xylene gave minimal or no product. Different combinations of temperature and reaction time couldn’t improve the yield. Among the various Lewis acids tested, AlCl₃ gave the best result, while CuCl, ZnCl2, PdCl2 and Sc(OTf)3 showed moderate conversions (30–55%), and InCl3 had the lowest efficiency. Without any Lewis acid we observed no conversion by LC–MS (Table 1, entry 16). During the reaction, IMDA adduct 7a was detected by LC–MS (Figure S1, Supporting Information File 1), but it was not stable enough for isolation. The structure of 8a was confirmed by single crystal X-ray diffraction analysis.

Table 1: Optimization of IMDA and re-aromatization reactions for the preparation of 8a.

[Graphic 1]
entry catalyst
(10 mol %)
solvent temp
(°C)
time conversion
(%)
1 AlCl3 toluene 120 12 h 0
2 FeCl3 1,2-dichlorobenzene 120 (μw) 1 h 0
3 AlCl3 1,2-dichlorobenzene 180 4 h 85
4 AlCl3 1,2-dichlorobenzene 180 (μw) 1 h 5
5 AlCl3 1,2-dichlorobenzene 120 (μw) 2 h 15
6 AlCl3 xylene 140 4 h 0
7 ZnCl2 1,2-dichlorobenzene 140 4 h 50
8 CuCl 1,2-dichlorobenzene 180 4 h 55
9 PdCl2 1,2-dichlorobenzene 180 4 h 40
10 CsF 1,2-dichlorobenzene 180 4 h 30
11 Sc(OTf)3 1,2-dichlorobenzene 180 4 h 35
12 CsCO3 1,2-dichlorobenzene 180 4 h 30
13 InCl3 1,2-dichlorobenzene 180 4 h 20
14 Yb(OTf)3 1,2-dichlorobenzene 180 4 h 60
15 NiCl2 1,2-dichlorobenzene 180 4 h 47
16 no catalyst 1,2-dichlorobenzene 180 4 h 0

The optimized reaction conditions were used to evaluate the substrate scope of the synthesis of imidazopyridine-fused isoquinolinones 8 (Scheme 3). The R1 residue on the furan ring was found to have the most significant impact on the IMDA reaction. A bromine atom at the 3- or the 4-position resulted in products 8ai in 66–86% yields, while a bromine atom or a methyl group at the 5-position inhibited the IMDA reaction in the preparation of 8j and 8k. A comprehensive DFT investigation of reactant 6 was carried out to analyze the transition state of the IMDA reaction for a Br-substituted diene and its charge distribution (Figure 2). The diene has a notable positive charge (+0.318, +0.098, 6a), (+0.334, +0.082, 6h) and (+0.316, +0.074, 6r) whereas the dienophile presents a negative charge (−0.280 to −0.325, 6a), (−0.280 to −0.327, 6h) and (−0.280 to −0.327, 6r), respectively. This structure induces electrostatic repulsion instead of the requisite attraction for a successful interaction between the electron-rich diene and the electron-deficient dienophile, characteristic of Diels–Alder processes. The incorporation of a bromine atom at the 5-position of the diene (+0.306, −0.041, 6j) complicates the situation. As an electronegative element, Br exerts an inductive electron-withdrawing influence to enhance the electron shortage of the diene. This electronic imbalance reduces the diene's nucleophilicity, rendering it less reactive to the dienophile. The unfeasibility of the IMDA reaction in this system arises from inadequate interatomic distances, electrostatic repulsion from incompatible associated dienophile was conducted . Firstly, the charge and the electronic consequences of the 5-Br substitution 6j were considered, which were found to inhibit the system from attaining the requisite conditions for successful cycloaddition. Secondly, the interatomic distances between the reactive centers of the diene and dienophile are almost similar for all substitutes of 6a, 6h, 6r and 6j, which, are not ideal effective for IMDA cycloadditions compared to the other substitute cycloadditions.

[1860-5397-21-92-i3]

Scheme 3: Substrate scope for IMDA and dehydrative aromatization in making 8. Reaction conditions: 6 and AlCl3 (10 mol %) in 1,2-dichlorobenzene at 180 °C for 4 h.

[1860-5397-21-92-2]

Figure 2: Transition state analysis of IMDA reactions for 6a, 6j, 6h and 6r.

The R2 substituent on the imidazopyridine moiety in 6 was found to have a significant electronic impact on the IMDA cycloaddition. When R2 is a halogen (Br or Cl), it withdraws electron density through its inductive (−I) effect to increase diene reactivity for the cycloaddition to form 7. For example, 6l (R2 = 6-Cl, 68% yield of 8l), 6m (R2 = 6-Br, 80% yield of 8m), and 6n (R2 = 7-Br, 84% yield of 8n) are high-yielding substrates. But an electron-donating group in 6o (R2 = 5-methyl) lowers the dienophilic nature and gave no product 8o. The R3 substituent from isocyanides is an important factor in forming intermediates 7 and promoting dehydrative aromatization for making products 8. The reactions with R3 = n-butyl resulted in the high yielding formation of 8a,h,l,m,n and 8r (68–85%), R3 = phenyl resulted in 8b,g and 8q in 78–82% yields, R3 = isopropyl and cyclopentene gave 8c,f,p and 8d in greater than 70% yields, and R3 = 2-morpholinoethyl gave 8e,i and 8s in 60–76% yields.

The energy status for the transformation of compound 6a to 8a was calculated using the Gaussian 16 software (Figure 3) . The N-acylated compound 6a has a baseline relative energy of 0 kJ/mol, while the transition state of the Diels–Alder (TS-DA) reaction presents the highest energy barrier at 1.221 kJ/mol. The DA adduct shows a little lower energy at 1.001 kJ/mol, indicating a smooth transition from the transition state to the product. The final dehydrative ring-opening gives products by decreasing the energy to 0.978 kJ/mol. Computational analysis indicates that the IMDA step has a high energy barrier which needs a catalyst, while the dehydrative re-aromatization step is energetically favorable.

[1860-5397-21-92-3]

Figure 3: Relative energy diagram for the synthesis of 8a from 6a.

Other than furfural, thiophene-2-carbaldehyde (2s) was used for the GBB and N-acylation reactions to make 6t (Scheme 4). The IMDA reaction of 6t was carried out under the catalysis of AlCl3 in dichlorobenzene at 180 °C for up to 24 h, but no compounds 7t and 8t could be detected by LC–MS from the reaction mixture. The X-ray structure of 6t indicated that the diene and dienophile are perpendicular to each other which prevents them from being properly aligned for the IMDA reaction. The transition state of the IMDA is electronically destabilized by the sulfur group of the thiophene to reduce the diene's reactivity or altering the electrophilicity of the dienophile.

[1860-5397-21-92-i4]

Scheme 4: Using thiophene-2-carbaldehyde for the synthesis of 8t.

Based on the computational analysis of the transition states, reaction mechanisms for the IMDA and the dehydration re-aromatization process are proposed in Scheme 5. In the IMDA reaction for the preparation of intermediate 7, the carbonyl oxygen interacts with AlCl₃, enhancing the electrophilicity and promoting the rearrangement to form stable oxonium ions. The removal of water from 7 is facilitated by protonation, producing reactive carbocations which undergo dehydrative aromatization to produce products 8.

[1860-5397-21-92-i5]

Scheme 5: Proposed mechanisms for IMDA reaction and dehydration re-aromatization.

Conclusion

In summary, we developed a reaction sequence involving GBB, N-acylation, IMDA and dehydrative re-aromatization reactions for the synthesis of imidazopyridine-fused isoquinolinones. Computational studies of the IMDA reaction indicated that the position of the R1 group on the furan ring and the R2 group on the imidazopyridine moiety have direct electronic impact on the IMDA reaction. This integrated reaction process provided a new avenue for the preparation of heterocyclic scaffolds with potential biological activity.

Experimental

General procedure for the synthesis of intermediates 4 and 6

The GBB reactions for the preparation of imidazo[1,2-a]pyridines 4 were conducted using aminopyridines 1 (0.5 mmol), isocyanides 3 (0.6 mmol, 1.2 equiv), and furfuraldehyde 2 (0.6 mmol, 1.2 equiv) in 3:1 DCM/MeOH (4 mL) with Yb(OTf)3 (0.04 mmol, 0.08 equiv) as a Lewis acid catalyst under microwave irradiation at 100 °C for 1 h (Scheme 2, Table S1 in Supporting Information File 1). Nineteen distinct adducts 4 were obtained in 89–98% yields. The reactions of GBB adducts 4 with acryloyl chloride (5, 1.5 equiv) in the presence of Et3N (2 equiv) at room temperature in anhydrous CH2Cl2 for 6 h afforded 19 N-acylated compounds 6 in 80–90% yields after flash chromatography with 1:6 EtOAc/hexanes (Scheme 2, Table S2 in Supporting Information File 1) .

General procedure for the synthesis of products 8

In the presence of 0.08 equiv of Lewis’s acid AlCl3, N-acylation products 6 (0.1 mmol) in dichlorobenzene were heated at 180 °C for 4 h (Scheme 3). The reaction mixtures were checked by LC–MS to follow the formation of DA adducts 7 and the ring opening products 8 (Figure S1, Supporting Information File 1). After 4 h, the reaction mixtures were worked up and the crude products were purified by flash chromatography with 30:70 EtOAc/hexanes. Product structures were confirmed by 1H and 13C NMR analysis and X-ray crystal structure analysis of 8a.

Density functional theory (DFT) calculations

DFT computations were conducted utilizing Gaussian 16W with the B3LYP functional and the 6-31G(d,p) basis set . Geometry optimizations were performed without symmetry restrictions, and frequency analyses verified that all structures represented genuine minima. Charge distributions and interatomic distances were evaluated to determine reaction feasibility, utilizing GaussView for molecular visualization.

Supporting Information

Supporting Information File 1: General reaction procedures, compound characterization data, and copies of NMR spectra.
Format: PDF Size: 3.1 MB Download

Conflict of Interest

The authors declare no competing financial interest.

Author Contributions

Ashutosh Nath: data curation; formal analysis; investigation; methodology; software; validation; writing – original draft. John Mark Awad: investigation; methodology; validation; writing – original draft. Wei Zhang: conceptualization; funding acquisition; supervision; writing – review & editing.

Data Availability Statement

All data that supports the findings of this study is available in the published article and/or the supporting information of this article.

References

  1. Krasavin, M.; Dar'in, D.; Balalaie, S. Tetrahedron Lett. 2021, 86, 153521. doi:10.1016/j.tetlet.2021.153521
    Return to citation in text: [1]
  2. Shen, G.-B.; Yu, T.; Zhang, Y.-L.; Ma, L.-P.; Chen, L.; Lu, J.-J.; Meng, T. J. Heterocycl. Chem. 2018, 55, 814–820. doi:10.1002/jhet.3102
    Return to citation in text: [1]
  3. Qian, Z.; Yang, A.; An, W.; Yu, T.; Wang, X.; Zhang, Y.; Shen, J.; Meng, T. RSC Adv. 2014, 4, 50947–50949. doi:10.1039/c4ra09196e
    Return to citation in text: [1]
  4. Tang, L.; Ren, J.; Ma, Y.; Wang, X.; Chen, L.; Shen, J.; Chen, Y.-L.; Xiong, B. Tetrahedron Lett. 2016, 57, 2311–2314. doi:10.1016/j.tetlet.2016.04.050
    Return to citation in text: [1]
  5. Srinivasulu, V.; Khanfar, M.; Omar, H. A.; ElAwady, R.; Sieburth, S. M.; Sebastian, A.; Zaher, D. M.; Al-Marzooq, F.; Hersi, F.; Al-Tel, T. H. J. Org. Chem. 2019, 84, 14476–14486. doi:10.1021/acs.joc.9b01919
    Return to citation in text: [1]
  6. Tandi, M.; Sharma, V.; Gopal, B.; Sundriyal, S. RSC Adv. 2025, 15, 1447–1489. doi:10.1039/d4ra06681b
    Return to citation in text: [1]
  7. Dömling, A.; Wang, W.; Wang, K. Chem. Rev. 2012, 112, 3083–3135. doi:10.1021/cr100233r
    Return to citation in text: [1]
  8. Flores-Reyes, J. C.; Islas-Jácome, A.; González-Zamora, E. Org. Chem. Front. 2021, 8, 5460–5515. doi:10.1039/d1qo00313e
    Return to citation in text: [1]
  9. Slobbe, P.; Ruijter, E.; Orru, R. V. A. Med. Chem. Commun. 2012, 3, 1189–1218. doi:10.1039/c2md20089a
    Return to citation in text: [1]
  10. Boltjes, A.; Dömling, A. Eur. J. Org. Chem. 2019, 7007–7049. doi:10.1002/ejoc.201901124
    Return to citation in text: [1] [2] [3]
  11. Cai, Q.; Liu, M.-C.; Mao, B.-M.; Xie, X.; Jia, F.-C.; Zhu, Y.-P.; Wu, A.-X. Chin. Chem. Lett. 2015, 26, 881–884. doi:10.1016/j.cclet.2014.12.016
    Return to citation in text: [1]
  12. Erhorn, S. Zolpidem. In xPharm: The Comprehensive Pharmacology Reference; Enna, S. J.; Bylund, D. B., Eds.; Elsevier: New York, NY, USA, 2007; pp 1–5. doi:10.1016/b978-008055232-3.62888-0
    Return to citation in text: [1]
  13. Schneier, F. R.; Carrasco, J. L.; Hollander, E.; Campeas, R.; Fallon, B.; Saoud, J. B.; Feerick, J.; Liebowitz, M. R. J. Clin. Psychopharmacol. 1993, 13, 150–153. doi:10.1097/00004714-199304000-00011
    Return to citation in text: [1]
  14. Devi, N.; Rawal, R. K.; Singh, V. Tetrahedron 2015, 71, 183–232. doi:10.1016/j.tet.2014.10.032
    Return to citation in text: [1]
  15. Martini, C.; Mardjan, M. I. D.; Basso, A. Beilstein J. Org. Chem. 2024, 20, 1839–1879. doi:10.3762/bjoc.20.162
    Return to citation in text: [1]
  16. Veljkovic, I.; Zimmer, R.; Reissig, H.-U.; Brüdgam, I.; Hartl, H. Synthesis 2006, 2677–2684. doi:10.1055/s-2006-942506
    Return to citation in text: [1]
  17. Kesteleyn, B. R. R.; Schepens, W. B. G. HIV inhibiting 3,4-dihydro-imidazo[4,5-b]pyridin-5-ones. U.S. Patent US 7,994,187 B2, Aug 9, 2011.
    Return to citation in text: [1]
  18. Lu, Q.; Huang, X.; Song, G.; Sun, C.-M.; Jasinski, J. P.; Keeley, A. C.; Zhang, W. ACS Comb. Sci. 2013, 15, 350–355. doi:10.1021/co400026s
    Return to citation in text: [1]
  19. Paulvannan, K.; Stille, J. R. J. Org. Chem. 1992, 57, 5319–5328. doi:10.1021/jo00046a011
    Return to citation in text: [1] [2] [3]
  20. Rae, R. L.; Żurek, J. M.; Paterson, M. J.; Bebbington, M. W. P. Org. Biomol. Chem. 2013, 11, 7946–7952. doi:10.1039/c3ob41616j
    Return to citation in text: [1]
  21. Gaussian 16, Revision C.01; Gaussian, Inc.: Wallingford, CT, 2016.
    Return to citation in text: [1] [2]
  22. Ali, M. A.; Nath, A.; Islam, M. M.; Shaheed, S. B.; Dibbo, I. N. RSC Adv. 2022, 12, 11255–11261. doi:10.1039/d2ra00450j
    Return to citation in text: [1]
Other Beilstein-Institut Open Science Activities